Semler Scientific, Inc.

NasdaqCM SMLR

Semler Scientific, Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 33.13

Semler Scientific, Inc. Price to Earnings Ratio (P/E) is 33.13 on January 14, 2025, a 86.18% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Semler Scientific, Inc. 52-week high Price to Earnings Ratio (P/E) is 43.52 on December 17, 2024, which is 31.37% above the current Price to Earnings Ratio (P/E).
  • Semler Scientific, Inc. 52-week low Price to Earnings Ratio (P/E) is 7.86 on May 08, 2024, which is -76.26% below the current Price to Earnings Ratio (P/E).
  • Semler Scientific, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 17.19.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NasdaqCM: SMLR

Semler Scientific, Inc.

CEO Dr. Douglas Murphy-Chutorian M.D.
IPO Date Feb. 21, 2014
Location United States
Headquarters 2340-2348 Walsh Avenue
Employees 92
Sector Health Care
Industries
Description

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Similar companies

INGN

Inogen, Inc.

USD 10.62

2.81%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

TMDX

TransMedics Group, Inc.

USD 62.54

-2.36%

TELA

TELA Bio, Inc.

USD 2.74

-1.44%

CVRX

CVRx, Inc.

USD 16.15

7.38%

LIVN

LivaNova PLC

USD 47.63

0.66%

DCTH

Delcath Systems, Inc.

USD 12.69

-0.78%

ELMD

Electromed, Inc.

USD 31.05

1.90%

APYX

Apyx Medical Corporation

USD 1.43

-4.03%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email